Jean Kévin, Donnelly Christl A, Ferguson Neil M, Garske Tini
MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
Am J Trop Med Hyg. 2016 Dec 7;95(6):1435-1439. doi: 10.4269/ajtmh.16-0401. Epub 2016 Oct 10.
Despite previous evidence of high level of efficacy, no synthetic metric of yellow fever (YF) vaccine efficacy is currently available. Based on the studies identified in a recent systematic review, we conducted a random-effects meta-analysis of the serological response associated with YF vaccination. Eleven studies conducted between 1965 and 2011 representing 4,868 individual observations were included in the meta-analysis. The pooled estimate of serological response was 97.5% (95% confidence interval [CI] = 82.9-99.7%). There was evidence of between-study heterogeneity (I = 89.1%), but this heterogeneity did not appear to be related to study size, study design, or seroconversion measurement or definition. Pooled estimates were significantly higher (P < 0.0001) among studies conducted in nonendemic settings (98.9%, 95% CI = 98.2-99.4%) than among those conducted in endemic settings (94.2%, 95% CI = 83.8-98.1%). These results provide background information against which to evaluate the efficacy of fractional doses of YF vaccine that may be used in outbreak situations.
尽管先前有证据表明黄热病(YF)疫苗具有很高的效力,但目前尚无黄热病疫苗效力的综合衡量指标。基于近期一项系统评价中确定的研究,我们对与黄热病疫苗接种相关的血清学反应进行了随机效应荟萃分析。荟萃分析纳入了1965年至2011年间进行的11项研究,共4868个个体观察数据。血清学反应的合并估计值为97.5%(95%置信区间[CI]=82.9 - 99.7%)。存在研究间异质性的证据(I² = 89.1%),但这种异质性似乎与研究规模、研究设计或血清转化测量方法或定义无关。在非流行地区进行的研究中的合并估计值(98.9%,95%CI = 98.2 - 99.4%)显著高于在流行地区进行的研究(94.2%,95%CI = 83.8 - 98.1%)(P < 0.0001)。这些结果提供了背景信息,可据此评估在疫情暴发情况下可能使用的黄热病疫苗分剂量的效力。